The importance of a preschool booster for children born to hepatitis B-positive mothers

作者: S. N. Ladhani , M. E. Ramsay

DOI: 10.1136/ARCHDISCHILD-2013-303652

关键词: PediatricsBooster doseBooster (rocketry)VaccinationVirusHepatitis BTransmission (medicine)MedicineHepatocellular carcinomaCirrhosis

摘要: Chronic hepatitis B virus (HBV) infection is associated with cirrhosis, hepatic failure and hepatocellular carcinoma in later life. The risk of developing chronic inversely related to age at infection, ranging from 90% babies born mothers who are e-antigen-positive. WHO, therefore, recommends universal childhood immunisation commencing birth.1 In the UK, endemic HBV transmission contributes only a small proportion new infections, most cases arising immigration established carriers.2 Universal vaccination, does not meet currently acceptable criteria for cost-effectiveness.3 Instead, selective strategy targeting high-risk groups, including infants HBV-positive women, has been adopted.4 As part this approach, UK historically recommended booster dose individuals continued around 3–5 years after primary immunisation. antenatal screening was implemented April 2000 consistently achieved high coverage rates …

参考文章(7)
M Ruby Siddiqui, Nigel Gay, W John Edmunds, Mary Ramsay, None, Economic evaluation of infant and adolescent hepatitis B vaccination in the UK. Vaccine. ,vol. 29, pp. 466- 475 ,(2011) , 10.1016/J.VACCINE.2010.10.075
David Sloan, Mary Ramsay, Leonie Prasad, David Gelb, Chong Gee Teo, Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. Vaccine. ,vol. 23, pp. 5500- 5508 ,(2005) , 10.1016/J.VACCINE.2005.07.040
Isabelle Giraudon, Nadia Permalloo, Grainne Nixon, Andre Charlett, Sandra Cohuet, Sema Mandal, Mary Ramsay, Bharat C Patel, Helen Maguire, None, Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: A London study in 2006 Vaccine. ,vol. 27, pp. 2016- 2022 ,(2009) , 10.1016/J.VACCINE.2008.12.016
Susan Hahné, Mary Ramsay, Koye Balogun, W John Edmunds, Philip Mortimer, None, Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. Journal of Clinical Virology. ,vol. 29, pp. 211- 220 ,(2004) , 10.1016/J.JCV.2003.09.016
Pavel Teoharov, Ani Kevorkyan, Nedyalka Petrova, Ivan Baltadzhiev, Pierre Van Damme, Immune Memory and Immune Response in Children From Bulgaria 5–15 Years After Primary Hepatitis B Vaccination The Pediatric Infectious Disease Journal. ,vol. 32, pp. 51- 53 ,(2013) , 10.1097/INF.0B013E31826F354E
T. A. Yates, K. Paranthaman, L.-M. Yu, E. Davis, S. Lang, S. J. Hackett, S. B. Welch, A. J. Pollard, M. D. Snape, UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposure Archives of Disease in Childhood. ,vol. 98, pp. 429- 433 ,(2013) , 10.1136/ARCHDISCHILD-2012-302153
Elizabeth H. Boxall, Jaswant A. Sira, Naima El‐Shuhkri, Deirdre A. Kelly, Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. The Journal of Infectious Diseases. ,vol. 190, pp. 1264- 1269 ,(2004) , 10.1086/423818